Patent · US Active

Compounds for treatment of trypanosomes and neurological pathogens and uses thereof

US10399966B2 · kind B2 · utility

0Cited by
1References
10Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJan 20, 2017
Grant dateSep 3, 2019
Priority date
Expiry dateJan 20, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D513/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to novel compounds that cross the blood-brain barrier and are effective inhibitors of neurological pathogens such as trypanosomes. The invention further relates to the use of these compounds for treating disorders related to trypanosomes and neurological pathogens.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.